Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-transfer of umbilical cord blood to prevent primary graft failure after haploidentical transplantation
ChiCTR-OPC-15006672Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jan 1990
- Modality
- Bone Marrow HSCs → Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Peripheral Blood HSCs → Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of umbilical cord blood in hematopoietic malignancies, sponsored by Peking University People's Hospital. Primary endpoint: Engraftment time. Started Jan 1990; status: recruiting.
02
Drugs
umbilical cord blood
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ChiCTR-OPC-15006672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006672.